188 related articles for article (PubMed ID: 19829301)
1. Melanoma thickness trends in the United States, 1988-2006.
Criscione VD; Weinstock MA
J Invest Dermatol; 2010 Mar; 130(3):793-7. PubMed ID: 19829301
[TBL] [Abstract][Full Text] [Related]
2. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
3. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
Landow SM; Gjelsvik A; Weinstock MA
J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
[TBL] [Abstract][Full Text] [Related]
4. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
[TBL] [Abstract][Full Text] [Related]
5. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
6. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
Shaikh WR; Xiong M; Weinstock MA
Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
[TBL] [Abstract][Full Text] [Related]
7. Melanoma surveillance in the United States: overview of methods.
Watson M; Johnson CJ; Chen VW; Thomas CC; Weir HK; Sherman R; Cockburn M; Jackson-Thompson J; Saraiya M
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S6-16. PubMed ID: 22018069
[TBL] [Abstract][Full Text] [Related]
8. Comparative mortality of patients diagnosed with localized and in situ melanomas.
Harrison RA; Soong SJ; Lee JA
J Insur Med; 1998; 30(3):157-68. PubMed ID: 10351176
[TBL] [Abstract][Full Text] [Related]
9. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009.
Shaikh WR; Dusza SW; Weinstock MA; Oliveria SA; Geller AC; Halpern AC
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563354
[TBL] [Abstract][Full Text] [Related]
10. Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?
Shahnam A; Roder DM; Tracey EA; Neuhaus SJ; Brown MP; Sorich MJ
J Eval Clin Pract; 2014 Feb; 20(1):74-80. PubMed ID: 24112148
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
12. Superficial Spreading Melanomas in Children: An Analysis of Outcomes Using the Surveillance, Epidemiology, and End Results (SEER) Database.
Allan BJ; Ovadia S; Tashiro J; Thaller SR
Ann Plast Surg; 2015 Sep; 75(3):327-31. PubMed ID: 24667880
[TBL] [Abstract][Full Text] [Related]
13. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
14. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
Schneider JS; Moore DH; Mendelsohn ML
J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
[TBL] [Abstract][Full Text] [Related]
15. Increasing burden of melanoma in the United States.
Linos E; Swetter SM; Cockburn MG; Colditz GA; Clarke CA
J Invest Dermatol; 2009 Jul; 129(7):1666-74. PubMed ID: 19131946
[TBL] [Abstract][Full Text] [Related]
16. The incidence of malignant melanoma in the United States: issues as we approach the 21st century.
Rigel DS; Friedman RJ; Kopf AW
J Am Acad Dermatol; 1996 May; 34(5 Pt 1):839-47. PubMed ID: 8632084
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
18. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007.
Feng Z; Wu X; Chen V; Velie E; Zhang Z
J Cutan Pathol; 2011 Aug; 38(8):616-24. PubMed ID: 21518379
[TBL] [Abstract][Full Text] [Related]
19. Trends in incidence of thick, thin and in situ melanoma in Europe.
Sacchetto L; Zanetti R; Comber H; Bouchardy C; Brewster DH; Broganelli P; Chirlaque MD; Coza D; Galceran J; Gavin A; Hackl M; Katalinic A; Larønningen S; Louwman MWJ; Morgan E; Robsahm TE; Sanchez MJ; Tryggvadóttir L; Tumino R; Van Eycken E; Vernon S; Zadnik V; Rosso S
Eur J Cancer; 2018 Mar; 92():108-118. PubMed ID: 29395684
[TBL] [Abstract][Full Text] [Related]
20. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
